IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave
Shield Therapeutics PLC - commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Chief Financial Officer Hans-Peter Rudolf will leave the company next...
Thu, 12/10/2023 - 11:14